Aprea Therapeutics, Inc. (APRE) NASDAQ

1.46

+0.0152(+1.05%)

Updated at September 26 04:00PM

Currency In USD

Valuation

Market Cap18.13M
Enterprise Value-4.72M
P/E Ratio-0.64
PEG Ratio-0.3
Price/Sales Ratio12.53
Price/Book Ratio0.63
Enterprise/Revenue-11.83
Enterprise/EBITDA0.54

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-20.41
Operating Margin-21.81

Management Effectiveness

Return On Assets-0.8
Return On Equity-0.75

Income Statement

Revenue1.5M
Revenue/Share0.11
Gross Profit1.48M
EBITDA-12.94M
Net Income-12.96M
Diluted EPS-2.35

Balance Sheet

Total Cash16.53M
Total Cash/Share2.72
Total Debt0
Total Debt/Equity0
Current Ratio5.34
Book Value Per Share2.21

Price History

52-Week Change-46.91
52-Week High5.01
52-Week Low1.37
Moving Average 50 Days1.63
Moving Average 200 Days2.24

Statistics

Average Volume46,377
Shares Outstanding5.83M
% Held by Institutions29.84

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateFebruary 13, 2023